Mon, Oct 10, 2016
With an aim to boost its healthcare business, Piramal Enterprises announced on Monday that its UK-based unit Piramal Critical Care will acquire five anesthesia and pain management injectable products from Janssen Pharmaceutica NV for an upfront consideration of $155 million (nearly Rs 1,031.2 cr
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
